IP Library › Granted Patent US 10,932,925
Granted Patent B2
US 10,932,925 · App. 16/229,200 · Granted Mar 2, 2021

Stent

Inventor: Eric K. Mangiardi (Charlotte, NC)
Assignee: Q3 MEDICAL DEVICES LIMITED
A61F2/844A61B17/7233A61B17/7258A61B17/7283A61F2/82A61B17/7266A61B17/7291A61F2/06A61F2002/041A61F2002/048A61F2002/068A61F2002/30289A61F2230/0091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,932,925
App. No.
16/229,200
Granted
Mar 2, 2021
Kind
B2
Abstract

A bioabsorable stent is disclosed. The stent is made of a polymer and/or non-polymer material and has an elongated body having a proximate end, a distal end, and at least one open channel formed on the exterior surface of the elongated body to provide fluid communication between the proximal end and the distal end. Also disclosed is a bioabsorable stent having an elongated center rod having a proximate end and a distal end and a plurality of leaflets extending outward from the center rod and forming channels between two neighboring leaflets to provide fluid communication between the proximal end and the distal end.

Claims (29)

1. A method of using a stent, comprising the step of:

delivering the stent to a treatment site in a body lumen,

wherein the stent comprises an elongated body having a proximal end, a distal end, a central axis, a center lumen and at least one open sinusoidally undulating channel helically and longitudinally wound around the central axis, said channel extending from the proximal end to the distal end of the elongated body,

wherein the undulating channel is formed on exterior surfaces of the elongated body and allows fluid communication between the proximal end and the distal end to occur in contact with the exterior surface of the elongated body,

wherein the undulating channel is not in fluid communication with the center lumen, and

wherein the elongated body comprises a bioabsorbable material.

2. The method of claim 1 , wherein the elongated body comprises a plurality of sinusoidally undulating channels helically and longitudinally wound around the central axis, wherein the undulating channels are formed on the exterior surface of the body.

3. The method of claim 1 , wherein the elongated body has a sinusoidal shape.

4. The method of claim 1 , wherein the body further comprising an anchoring device.

5. The method of claim 1 , wherein the body further comprises a biological agent.

6. The method of claim 5 , wherein the biological agent is selected from the group consisting of chemotherapeutic agents, antimicrobial agents and gene transfer agents.

7. The method of claim 1 , wherein the at least one sinusoidal channel is formed by compressible channel walls that can be compressed against each other in a compressed state to reduce the diameter of the stent.

8. The method of claim 1 , wherein the stent has a pre-implantation diameter D pre , and is in situ expandable upon absorption of a body fluid to a post-implantation diameter D post , wherein D post is greater than D pre .

9. The method of claim 1 , wherein the bioabsorbable material is a hydrogel.

10. The method of claim 1 , wherein the at least one open sinusoidally undulating channel varies in width.

11. The method of claim 1 , wherein the at least one open sinusoidally undulating channel varies in depth.

12. The method of claim 1 , wherein the at least one open sinusoidally undulating channel varies in pitch.

13. The method of claim 1 , wherein the proximate end is a tapered end and the stent comprises a magnesium core coated with a hydrogel.

14. The method of claim 13 , wherein the hydrogel comprises chitin, chitosan, N-acylchitosan, or a combination thereof.

15. The method of claim 13 , wherein the stent is sized to be insertable into the canal of a bone having a fracture.

16. The method of claim 13 , wherein the stent comprises channel walls capable of being twisted against each other to reduce stent diameter.

17. The method of claim 16 , wherein the stent comprises channel walls capable of being rotated pivotally to collapse into each other to reduce stent diameter and being rotated in an opposite direction to restore to an extended state.

18. The method of claim 1 , wherein the stent is delivered to the treatment site in the body lumen with a pusher rod that pushes the stent through a body channel.

19. A method of using a stent, comprising the step of:

delivering the stent to a treatment site in a body lumen,

wherein the stent comprises an elongated body having a proximal end, a distal end, a central axis, a center lumen and at least one open sinusoidally undulating channel helically and longitudinally wound around the central axis, said channel extending from the proximal end to the distal end of the elongated body,

wherein the undulating channel is formed on the exterior surface of the elongated body fluid communication between the proximal end and the distal end to occur in contact with the exterior surface of the elongated body,

wherein the undulating channel is not in fluid communication with the center lumen, and

wherein the elongated body that includes the undulating channel is made from a non-polymer material selected from the group consisting of stainless steel, cobalt alloys, titanium alloys, tantalum, niobium, tungsten and molybdenum.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2018
From: MANGIARDI, ERIC K.
To: Q3 MEDICAL DEVICES LIMITED
Reel/Frame 047858/0246 →
Continuity (4)
Continuation 14841196 · Aug 31, 2015
Continuation 12539314 · Aug 11, 2009
Continuation In Part 12417122 · Apr 2, 2009
Related Publication 20190125556A1 · May 2, 2019
Cited By (2)
US 12,343,269 US 12,746,134